Whitsett has also added a second new lens for use in cataract procedures — the RxSight Light Adjustable Lens.
The ClearView 3 lens showed success for improving patient vision in clinical trials. The team at Whitsett first performed surgery using the lens last month.
“The ClearView 3 from Lenstec has been designed with increased precision, accuracy and stability, which results in excellent long-term visual outcomes at near, intermediate and distance,” Jeffery Whitsett, MD, founder of the Whitsett Vision Group, said in a Sept. 26 press release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.